Continuous hemodiafiltration therapy reduces damage of multi-organs by ameliorating of HMGB1/TLR4/NFκB in a dog sepsis model

Int J Clin Exp Pathol. 2015 Feb 1;8(2):1555-64. eCollection 2015.

Abstract

In the present study, we investigated whether CVVH can reduce HMGB1, TLR4, NF-κB and other serum cytokine levels, preventing organ injury in a dog sepsis model. A total of 10 dogs were injected with LPS and treated with either CVVH group (n = 5) or nothing (Control, n = 5) for 24 h. EILSA was used for examining the concentration of TNF-α, IL-6, HMGB 1 and TLR4. The histological change of lung, liver and kidney tissues was determined. The mRNA expression of HMGB1, TLR4 and NF-κB was examined by RT-PCR. The protein of HMGB1 and phosphated NF-κB was examined by Western-blot. The levels of serum HMGB1 came to the peak at 8 h, 16 h and then declined. The LPS-induced increase in HMGB1 level was suppressed by CVVH compared with Control. Likewise, serum TNF-α and IL-6 levels decreased with CVVH along with a significant improvement in the function of main organs. Histologic examination revealed significant reduction in inflammation in lung; liver and kidney tissues harvested 24 h after CVVH compared with Control. The mRNA of HMGB1, TLR4 and NF-κB in the kidney was expressed at high level after LPS administration, which was significantly decreased by CVVH. The increased protein expression of HMGB1 and phosphated NF-κB was reduced after CVVH compared with control. CVVH by reducing the level of HMGB1, TLR4, NF-κB and other cytokines could weaken the cascade of cytokines and restore the immune system, and reduce the damage of important organs in sepsis.

Keywords: CVVH; HMGB1; NF-κB; TLR4; sepsis.

MeSH terms

  • Animals
  • Blotting, Western
  • Disease Models, Animal
  • Dogs
  • Enzyme-Linked Immunosorbent Assay
  • HMGB1 Protein / blood*
  • Hemodiafiltration / methods*
  • NF-kappa B / blood*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sepsis / blood
  • Sepsis / therapy*
  • Toll-Like Receptor 4 / blood*

Substances

  • HMGB1 Protein
  • NF-kappa B
  • Toll-Like Receptor 4